Ischemia reperfusion dysfunction changes model-estimated kinetics of myofilament interaction due to inotropic drugs in isolated hearts
2006

Effects of Inotropic Drugs on Heart Function After Ischemia

Sample size: 40 publication 10 minutes Evidence: moderate

Author Information

Author(s): Rhodes Samhita S, Camara Amadou KS, Ropella Kristina M, Audi Said H, Riess Matthias L, Pagel Paul S, Stowe David F

Primary Institution: Medical College of Wisconsin

Hypothesis

How do positive inotropic drugs affect cross-bridge kinetics and myofilament Ca2+ handling in isolated guinea pig hearts before and after ischemia?

Conclusion

The study reveals that ischemia reduces myofilament Ca2+ sensitivity and alters cross-bridge kinetics, but inotropic drugs can improve these parameters under certain conditions.

Supporting Evidence

  • Ischemia reduces myofilament Ca2+ sensitivity and cross-bridge kinetics.
  • Dopamine enhances cross-bridge kinetics after ischemia.
  • Dobutamine reduces myofilament Ca2+ sensitivity but improves cross-bridge kinetics.
  • Digoxin increases myofilament Ca2+ sensitivity after ischemia.
  • Levosimendan enhances contractility by increasing Ca2+ affinity after ischemia.

Takeaway

This study looks at how certain medicines can help the heart work better after it has been hurt by a lack of blood. Some medicines help the heart use calcium better, which is important for it to pump well.

Methodology

A four-state computational model was used to predict left ventricular pressure based on calcium transients measured in isolated guinea pig hearts.

Potential Biases

Changes in heart rate due to inotropic interventions may confound the conclusions drawn from the model parameters.

Limitations

The model relies on local calcium measurements that may not represent the entire heart and does not account for all protein-protein interactions.

Participant Demographics

Guinea pigs, specifically albino English short-haired guinea pigs.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1475-925X-5-16

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication